A B S T R A C T The effect of epinephrine on basal and insulin-stimulated glucose uptake in perfused hindlimbs offed rats was studied. Insulin increased glucose uptake in a dose-dependent manner from a basal value of 1.5+0.3 up to a maximum value of 5.3 ±0.9 ,umol/min per 100 g with 6 nM (1 mU/ml). Epinephrine at 10 nM and 0.1 ,uM also increased glucose uptake to 2.6±0.1 and 3.1±0.1 ,mol/min per 100 g, respectively. These same concentrations of epinephrine, however, suppressed the insulin-stimulated glucose uptake to 3.2±0.3 Amol/min per 100 g. Both the stimulatory and inhibitory effects of epinephrine on glucose uptake were completely reversed by propranolol, but were not significantly altered by phentolamine.
INTRODUCTION
Although the effects of epinephrine on muscle glycogen metabolism are well characterized, the actions of the catecholamine on glucose uptake by muscle are poorly defined. Although it is well established that epinephrine administration in vivo is associated with a decrease in glucose clearance (1) (2) (3) (4) (5) (6) , the in vitro data have not been consistent. Walaas and Walaas (7) showed 30 years ago that epinephrine could decrease glucose uptake in isolated rat diaphragm. Subsequent investigators have noted, however, that this inhibition is consistently seen when the muscle is incubated in phosphate-buffered medium (8) (9) (10) (11) , but not when a more physiological bicarbonate-buffered medium is used (9, 11) .
There has been a limited number of studies of the effects of epinephrine on the transport of nonmetabolized monosaccharides in rat diaphragm and soleus. Newsholme and Randle (12) reported that epinephrine at 0.1 mM moderately increased the uptake of D-3-0-methylglucose, but not D-xylose in diaphragm. More recently, Bihler and associates (13, 14) demonstrated an inhibitory effect of 10 nM-10 ,uM epinephrine on the transport of 3-0-methylglucose in rat diaphragm and soleus. At very high concentrations (0.1-1 mM) the catecholamine was reported to stimulate transport of the hexose in diaphragm, but not soleus (13, 14) .
An important aspect of epinephrine action on metabolism is its interaction with insulin. Surprisingly, there have been very few studies ofthe effects ofepinephrine on insulin-stimulated hexose uptake by skeletal muscle in vitro. Walaas (10) originally showed that epinephrine inhibited the effect of insulin on glucose uptake in rat diaphragm. Kipnis and Cori (15) then reported that epinephrine did not inhibit the stimulatory effect of insulin on 2-deoxyglucose uptake by rat diaphragm, but did decrease the phosphorylation of the sugar. Newsholme and Randle (12) similarly found that epinephrine did not alter insulin-induced xylose uptake in this tissue.
In almost all the reported studies of epinephrine actions on glucose uptake in muscle, rat diaphragms have been used, and it is not certain that the results are entirely applicable to voluntary skeletal muscle. The purpose of the present study was therefore to characterize the actions ofepinephrine in regulating basal and insulin-stimulated glucose uptake by voluntary skeletal muscle using the perfused rat hindlimb preparation. The actions ofthe catecholamine were further analyzed with respect to changes in glucose transport and phosphorylation.
METHODS
Hindlimb perfusion preparation and glucose uptake studies. Male rats of the Sprague-Dawley strain (Harland Industries) fed ad lib. and weighing 180-220 g were used in this study. The hindlimbs were perfused as described by Caldwell et al. (16) . The perfusion medium was made up of KrebsHenseleit bicarbonate buffer containing 4% bovine serum albumin (Pentex fraction V), 30% washed aged human erythrocytes and 10 mM D-glucose. The flow rate was maintained at -10 ml/min with Holter model 911 roller pumps (Extracorporeal Medical Specialties, Inc., King of Prussia, Pa.). The perfusate was recirculated for the first 20 min to allow equilibration ofthe preparation. This was then followed by a 30-min experimental perfusion period performed with nonrecirculation of medium. During the experimental period, a 0.9% NaCl solution containing 0.1% bovine serum albumin with or without hormones (insulin and/or epinephrine) was infused into the aortic line at 0.2 ml/min by means of a Harvard model 940 infusion pump (Harvard Apparatus Co., Inc., South Natick, Mass.). When adrenergic blockers were used, they were added to the perfusate as a single bolus and allowed to equilibrate throughout the system 10 min before hormone infusion. Plasma glucose and whole blood lactate, PO2 and pH were monitored in the arterial and venous samples drawn at 10-min intervals throughout the study.
Studies of 2-deoxyglucose and 3-0-methylglucose uptake. In studies of the uptake of nonmetabolized sugars, the protocol described for the glucose uptake studies was followed with the following modifications. At In the experiments with [3H]2-deoxyglucose, the frozen muscle samples were pulverized, deproteinized with 5% HCl04, and centrifuged. The supernatant fluids were neutralized and chromatographed on Dowex 1 x 8 (Cl-form) according to Olefsky (18 For measurement ofintracellular free glucose and glycolytic intermediates, thigh muscle tissue was freeze-clamped at the temperature of liquid N2 and pulverized at this temperature in a percussion mortar. Aliquots of frozen powder were homogenized in ice-cold 5% HCl04 (containing 4 mM NaEDTA) and centrifuged. The supernates were neutralized with 3 M K2CO3 and assayed enzymatically for glucose (19) , glucose-6-P and fructose-6-P (20) , and fructose-1,6-P2 and triose-P (21). Tissue glucose values were corrected for extracellular glucose which was determined from the tissue sucrose space and the perfusate plasma glucose concentration.
Statistical analysis of results. All statistical variations cited in the text are standard errors of the mean. Statistical analyses were carried out with Student's t test (22) .
Materials. Insulin was purchased from Eli Lilly Laboratories (Indianapolis, Ind.) and (-)-epinephrine bitartrate and (+)-propranolol HCI from Sigma Chemical Co., St. Louis, Mo. Phentolamine mesylate was from Ciba-Geigy Corporation 
RESULTS
Effects of insulin and epinephrine added alone on glucose uptake by perfused rat hindlimbs. Fig. 1A shows the response of glucose uptake by perfused rat hindlimbs to several concentrations of insulin. Insulin at 0.01 mU/ml (60 pM) was without effect, but at 0.1 mU/ml (0.6 nM) it increased glucose uptake from a basal value of 1.5±0.3 to 2.9+0.2 ,umol/min per 100 g of body wt (P < 0.01). Maximal stimulation (to 5.3±0.9 ,mol/min per 100 g) was observed with 1 mU/ml (6 
In contrast to the in vivo effect of epinephrine on the clearance of glucose (1) (2) (3) (4) (5) (6) , increasing concentrations of the hormone resulted in a stimulation of basal glucose uptake by the perfused hindlimb that was significant at 10 nM and 0.1 AM ( had no demonstrable effect on glucose uptake. Concentrations higher than 0.1 AM were not tested since perfusions with these concentrations were unsatisfactory, owing to a high incidence of edema. ' Inhibitory effect of epinephrine on insulin-stimulated glucose uptake by perfused rat hindlimbs. In contrast to its effects on basal glucose uptake, epinephrine had an inhibitory effect on glucose uptake by the perfused rat muscle if this process was stimulated by 1 mU/ml insulin (Fig. 1C) . Epinephrine at 1 nM again had no demonstrable effect on the insulinstimulated glucose uptake by the muscle. Increasing the concentration to 10 nM, however, resulted in a suppression of the stimulated glucose uptake from 4.9±0.2 to 3.3±0.2 ,umol/min per 100 g of body wt (P < 0.01). At a higher epinephrine concentration (0.1 ,uM), the insulin-stimulated glucose uptake could not be suppressed lower than 3.2±0.3 ,umol/min per 100 g, which is not different from the epinephrinestimulated glucose uptake in the absence of insulin (3.0±0.1 ,umol/min per 100 g, Fig. 1B , P > 0.25). Studies (not shown) ofthe time-course ofthe inhibitory effect of0.1 ,uM epinephrine on glucose uptake in hindlimbs perfused with 1 mU/ml insulin showed that inhibition was evident at 10 min and maximal between 20 and 30 min.
Effects of adrenergic blockers on the effects of epinephrine on glucose uptake by perfused rat hindlimbs. To determine the nature of the adrenergic receptor(s) mediating the effects of epinephrine on glucose uptake by skeletal muscle, the effects of the ,8-blocker propranolol and a-blocker phentolamine were tested. It was found that when propranolol was administered at 1 ,uM, both the stimulatory and inhibitory effects of epinephrine were abolished (Fig. 2) .
On the other hand, phentolamine at 1 AM did not significantly alter the stimulatory (P > 0.05) or inhibitory (P > 0.10) effects of epinephrine. Thus, both effects of the catecholamine are mediated primarily by 13-adrenergic receptors. Addition of either blocker alone did not affect basal glucose uptake (data not shown). FIGURE 2 Effects of adrenergic blockers on the stimulatory and inhibitory effects of epinephrine on glucose uptake by rat hindlimbs. Experimental conditions were as in Fig. 1 . The a-blocker was phentolamine and the l3-blocker was propranolol. They were added to the perfusate 10 min before the infusion of hormones. I designates insulin and E designates epinephrine.
Effects of insulin and epinephrine on the uptake and phosphorylation of 2-deoxyglucose in skeletal muscle. Although skeletal muscle is probably the major glucose-utilizing tissue in the hindlimb (23), the preceding studies did not identify this tissue as the site at which epinephrine was controlling glucose uptake. Nor did they define whether the catecholamine was altering glucose uptake by acting on glucose transport or phosphorylation. To gain information on these points, the uptake and phosphorylation of the glucose analogue [3H]2-deoxy-D-glucose in muscle was investigated. This hexose is converted to 2-deoxyglucose-6-P but is not further metabolized in muscle. The uptake ofthis compound was approximately linear over 30 min and was inhibited by increasing concentrations of glucose (data not shown). Fig. 3 shows the effects of hormones on the intracellular accumulation of [3H]2-deoxyglucose (free plus phosphorylated forms) during 10 and 30 min. As expected, insulin (1 mU/ml) stimulated the uptake of the hexose approximately sixfold, but epinephrine (0.1 ,uM) produced no significant effect on uptake in the absence of insulin at either 10 or 30 min. At 30 min, the catecholamine inhibited the action of insulin (P < 0.01), but this effect was not significant at 10 min (P > 0.5).
When free [3H]2-deoxyglucose was separated from [3H]2-deoxyglucose-6-P by ion-exchange chromatography (Methods), more striking effects of epinephrine were seen (Fig. 3) . In control and insulin-treated tissues, the hexose was mainly in the phosphorylated Effects of insulin and epinephrine on the uptake of 3-0-methylglucose in skeletal muscle. To confirm 2 In this series of experiments, the fraction of intracellular 2-deoxyglucose in the free form in the muscles perfused with insulin for 10 min was higher than that seen in two other series, in which insulin, but not epinephrine, was tested. In these, the percentage of the sugar in the free form was < 10% of total. Fig. 4 shows the hormone-induced changes in the intracellular accumulation of 3-0-methylglucose during 10 min. As expected, there was a large stimulation with insulin, but no changes were observed with epinephrine in the absence or presence of insulin. Changes in intracellular glucose and glycolytic intermediates induced by insulin and epinephrine in skeletal muscle. Since the studies with 2-deoxyglucose pointed to an inhibitory effect of epinephrine on the hexokinase reaction, this was explored further by measuring the intracellular concentrations of free glucose, glucose-6-P, and other glycolytic intermediates in muscle perfused with 10 mM glucose plus insulin and/or epinephrine (Fig. 5 ). In the control and insulin-treated muscle, free glucose was barely detectable. There was a significant (P < 0.01) accumulation of intracellular glucose in the presence of epinephrine FIGURE 5 Effects of insulin and epinephrine on intracellular glucose and glucose-6-P in muscle of perfused rat hindlimbs. Experimental conditions were as in Fig. 1 . Intracellular glucose and glucose-6-P were determined as described in Methods. Values are means of four to six experiments.
(0.4 ,umol/g), however, and this became much greater in the presence of both insulin and epinephrine (1.4 ,mol/g). Insulin did not significantly alter the concentration of glucose-6-P when infused alone (P > 0.1), whereas epinephrine markedly elevated this. Insulin also did not alter the accumulation of the hexose phosphate induced by epinephrine. Fructose-6-P levels were about one-fifth of those of glucose-6-P, and the hormone-induced changes paralleled those of glucose-6-P (data not shown). Fructose-1,6-P2 and triose-P were not altered by insulin, but were increased twofold by epinephrine in the absence or presence of insulin (data not shown). As will be discussed, these findings are consistent with inhibition of glucose phosphorylation by epinephrine due to the accumulation of glucose-6-P resulting from glycogenolysis.
DISCUSSION
Using the isolated perfused rat hindlimb preparation, we have demonstrated that epinephrine can have both a stimulatory and an inhibitory effect on peripheral glucose uptake. The stimulatory effect of epinephrine was seen on the basal nonstimulated glucose uptake, was mediated by (3- (12, 13) , but not in rat soleus muscle (14) . At more physiological concentrations (10 nM-0.1 uM), however, the catecholamine has been noted to exert an inhibitory effect (12, 13) . Unless there is a gross difference between the epinephrine sensitivity of rat diaphragm and skeletal muscle, these findings lend further support to the idea that muscle is not the site of the stimulatory effect of 10 nM-0.1 ,uM epinephrine on glucose uptake observed in the present study.3 Epinephrine was observed by early investigators to stimulate glucose uptake by adipose tissue (27, 28) . More recently, Ludvigsen et al. (29) have shown a stimulatory effect of the catecholamine on 3-0-Meglucose uptake in isolated rat adipocytes incubated in a bicarbonate buffer system, but not a phosphate buffer system. The effect was seen with 10 nM and 0.1 ,IM catecholamine and was inhibited by propranolol. These results indicate that adipose tissue is probably one of the sites at which epinephrine stimulates glucose uptake in the rat hindlimb.
The present findings indicate that the inhibitory effect of epinephrine on insulin-stimulated glucose uptake by the rat hindlimb can be attributed to changes in glucose metabolism in skeletal muscle, although other tissues may also be involved. Such an inhibitory effect on glucose utilization was reported earlier for rat diaphragm (10, 30) , but has not been observed in adipose tissue (27, 31, 32) . The present investigations indicate that the effect is not exerted on glucose transport. This was most clearly shown in the experiments with 3-0-methylglucose, which is transported on the glucose carrier but is not metabolized. It is also supported by the findings with 2-deoxyglucose, which although it also utilizes the glucose transport system undergoes intracellular phosphorylation without further metabolism. Additional support comes from epinephrine's ability to increase markedly the intracellular concentration of free glucose. This result is contrary to that expected if transport were inhibited.
On the other hand, the present results point to an inhibitory action of epinephrine on glucose phosphorylation. This would explain the accumulation of free glucose and 2-deoxyglucose, especially in the 3The situation in amphibians may be different from that in mammals since Wohltmann et al. (25) and Saha et al. (26) have reported that epinephrine (0.1-10 1sM) increases the transport of 3-0-methylglucose in frog sartorius.
presence of insulin where hexose entry is enhanced. Inhibition of the hexokinase reaction would also explain epinephrine's ability to decrease the fraction of 2-deoxyglucose in the phosphorylated form (Fig. 3) . It is interesting to note that in 1959, Kipnis et al. (33) reached a similar conclusion based on the changes in the concentration of free glucose in diaphragm and gastrocnemius in rats injected with epinephrine. In one animal injected with both epinephrine and insulin, they observed a very large accumulation ofintracellular glucose analogous to the present findings. In further studies in vitro, Kipnis and Cori (15) observed that epinephrine did not inhibit the uptake of 2-deoxyglucose by rat diaphragm in the presence of insulin, but that it did decrease the phosphorylation of the sugar. These findings are similar to ours at 10 min. At 30 min an inhibitory effect of epinephrine on insulin-stimulated glucose or 2-deoxyglucose uptake is evident in our studies, and can be attributed to an increase in sugar efflux consequent to the large increase in intracellular free hexose (relative to that seen with insulin alone).
Epinephrine has also been observed to increase intracellular glucose and to inhibit insulin-stimulated glucose uptake in frog sartorius muscles (25) . The rise in intracellular glucose was observed whether or not glucose was present in the external medium. This suggests that it may have been due to the action of amylo-1,6-glucosidase on limit dextrin produced by phosphorylase (34) in addition to inhibition of glucose phosphorylation. Such a mechanism could also contribute to the rise in intracellular glucose seen with epinephrine alone in the present study.
The present findings are entirely consistent with earlier explanations of the inhibitory effect of epinephrine on glucose uptake in muscle, namely that it results from inhibition of the hexokinase reaction due to the large rise in glucose-6-P and fructose-6-P induced by glycogenolysis (10, 15, 33) . In accord with previous findings on glycogenolysis (35) , the inhibitory effect of epinephrine on glucose uptake was totally inhibited by f8-adrenergic blockade, but unaffected by a-blockade. Furthermore, the inhibitory action of epinephrine on insulin-stimulated glucose uptake developed with a time course similar to that seen for the effect of epinephnne on the level of glucose-6-P (35) . Hexokinase from muscle resembles that from other tissues in that it is inhibited by concentrations of glucose-6-P within the range found in muscle in the present study (36) (37) (38) .4 4Some investigators have suggested that the increase in tissue glucose-6-P with epinephrine may not be important in the inhibition of glucose uptake in muscle (11, 39) . In one study (11) , this conclusion was reached on the basis of experiments with cell-free extracts, and no data actually contradicting a role for glucose-6-P were presented. In another study (39) , a synthetic inhibitor of cyclic AMP phosphodiesterase Epinephrine inhibition ofinsulin-stimulated glucose uptake by muscle would explain the inhibitory effect of the catecholamine on glucose clearance in vivo (1) (2) (3) (4) (5) (6) (7) . It should be recognized, however, that in the in vivo situation, glucose is taken up by many other tissues in addition to skeletal muscle, and it is likely that changes in some of these, e.g., liver, contribute to the effect. As is found for the inhibitory action of epinephrine on glucose uptake by skeletal muscle in vitro (39, 40, and Fig. 2) , the suppression of glucose clearance by epinephrine in vivo is mediated by f8-adrenergic receptors (2, 6) .
From a physiological viewpoint, the inhibitory effect of epinephrine on insulin stimulation of skeletal muscle glucose uptake is probably an important component ofthe reversal ofinsulin-induced hypoglycemia produced by increased sympathetic discharge, and could play a role in the overall regulation of blood glucose by the sympathetic nervous system.
